ArticlePreventive medicine reports2025
Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and Sarcopenic obesity in U.S. adults: a cross-sectional study.
Article in Preventive medicine reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Association Between NHHR and Future Cardiovascular Disease Among Patients With CKM Stages 0-3: A Nationwide Prospective Cohort Study.Journal of clinical hypertension (Greenwich, Conn.) · 2026Article
- Association of the non-HDL cholesterol to HDL cholesterol ratio with possible sarcopenic obesity in Chinese adults.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study examines the relationship between the ratio of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol (NHHR) and sarcopenic obesity in U.S. adults, utilizing data from the National Health and Nutrition Examination Survey (NHANES). Methods: We analysed data from NHANES collected between 2011 and 2018. Multivariable regression models assessed the NHHR-sarcopenic obesity relationship, and limited cubic spline analysis investigated potential non-linearity. We employed likelihood ratio tests to evaluate model fit and performed subgroup analyses to verify the consistency of our findings. Results: The analysis included 8601 participants with an average age of 39.94 ± 11.45 years. In the fully adjusted model, each unit increase in NHHR was associated with a 76 % higher likelihood of sarcopenic obesity (odds ratio [OR]: 1.76, 95 % confidence interval [CI]: 1.18-2.63). The relationship between NHHR and sarcopenic obesity was non-linear, with a significant breakpoint at 3.36. Below this threshold, each unit increase in NHHR significantly increased the risk of sarcopenic obesity (OR: 1.53, 95 % CI: 1.32-1.78), while above this threshold, NHHR had no significant effect on sarcopenic obesity prevalence. Conclusions: These results indicate a positive and non-linear association between NHHR and sarcopenic obesity, suggesting that NHHR, as a simple and widely available lipid marker, may assist in the early identification of individuals at risk of sarcopenic obesity. Further large-scale longitudinal studies are needed to validate its predictive value across broader age groups and to clarify its potential utility in personalized risk assessment and clinical screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.